A lecture titled "Vaccine Biotechnology: Nanovaccines" was delivered to students of Baku State University (BSU) by Professor Adil Abdullayev, Director of the V. Akhundov Research Institute for Medical Prevention.

During the event, Professor Abdullayev discussed in detail the principles of vaccine action, classical and modern vaccine types, and the structural and functional features of nanovaccines. He emphasized the advantages of nanoparticles, including antigen protection, targeted delivery to immune cells, and the ability to induce a strong immune response.

The lecture also highlighted key challenges of nanovaccines, such as the high cost of production, limited data on long-term toxicity and bioaccumulation, and the potential of certain nanomaterials to provoke excessive immune reactions. Ethical aspects—particularly the need for transparent safety testing and comprehensive risk–benefit assessment—were underlined.

In conclusion, it was noted that nanovaccines open new prospects for treating infectious diseases and cancer; however, broader application requires further research, safety evaluation, and adherence to strict ethical standards.

The session concluded with a Q&A segment, during which Professor Abdullayev answered students’ questions.